Ltd Cayman Bioventures Hbm

Affiliations

  • Large Shareholder at Mineralys Therapeutics Inc. (MLYS), 2023-02-17
  • Large Shareholder at Io Biotech Inc. (IOBT), 2021-11-12
  • Large Shareholder at Werewolf Therapeutics Inc. (HOWL), 2021-05-05
  • Large Shareholder at Nabriva Therapeutics Plc (NBRV), 2017-09-15
  • Large Shareholder at Nabriva Therapeutics Legacy Plc (NBRV), 2017-07-22
  • Large Shareholder at Paratek Pharmaceuticals Inc. (PRTK), 2015-06-02
  • Large Shareholder at Lpath Inc (LPTN), 2014-10-02
  • Large Shareholder at Ophthotech Corp. (OPHT), 2014-05-15
  • Large Shareholder at Ptc Therapeutics Inc. (PTCT), 2013-12-19
  • Large Shareholder at Pacira Pharmaceuticals Inc. (PCRX), 2013-03-26
  • Large Shareholder at Micrus Endovascular Corp (MEND), 2010-03-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MLYS $16.00 312,500 $5,000,000.00 3,218,106 2023-02-14 Filing
IOBT $14.00 325,000 $4,550,000.00 2,690,545 2021-11-09 Filing
OPHT $22.00 228,000 $5,016,000.00 3,639,902 2013-09-30 Filing
PTCT $15.00 666,676 $10,000,140.00 2,508,171 2013-06-25 Filing
PCRX $6.50 307,692 $1,999,998.00 3,445,289 2011-11-21 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NBRV $8.52 3,429 $29,223.65 2,334,128 2017-09-14 Filing
NBRV $8.54 22,721 $193,955.54 2,337,557 2017-09-13 Filing
NBRV $8.63 10,458 $90,235.81 2,360,278 2017-09-12 Filing
NBRV $9.50 639 $6,070.50 2,370,735 2017-08-31 Filing
NBRV $10.50 2,013 $21,137.10 2,371,374 2017-08-08 Filing